Search by Drug Name or NDC
NDC 55150-0393-01 AZACITIDINE 100 mg/4mL Details
AZACITIDINE 100 mg/4mL
AZACITIDINE is a INTRAVENOUS; SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Eugia US LLC. The primary component is AZACITIDINE.
Product Information
| NDC | 55150-0393 |
|---|---|
| Product ID | 55150-393_23509cbb-fa31-4369-98d1-2ce454828db9 |
| Associated GPIs | |
| GCN Sequence Number | 054660 |
| GCN Sequence Number Description | azacitidine VIAL 100 MG INJECTION |
| HIC3 | V1B |
| HIC3 Description | ANTINEOPLASTIC - ANTIMETABOLITES |
| GCN | 22663 |
| HICL Sequence Number | 026361 |
| HICL Sequence Number Description | AZACITIDINE |
| Brand/Generic | Generic |
| Proprietary Name | AZACITIDINE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | AZACITIDINE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route | INTRAVENOUS; SUBCUTANEOUS |
| Active Ingredient Strength | 100 |
| Active Ingredient Units | mg/4mL |
| Substance Name | AZACITIDINE |
| Labeler Name | Eugia US LLC |
| Pharmaceutical Class | Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA215066 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 55150-0393-01 (55150039301)
| NDC Package Code | 55150-393-01 |
|---|---|
| Billing NDC | 55150039301 |
| Package | 1 VIAL, SINGLE-DOSE in 1 CARTON (55150-393-01) / 4 mL in 1 VIAL, SINGLE-DOSE |
| Marketing Start Date | 2023-01-03 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |